HIGHLIGHTS
- who: Fu Hou Wong et al. from the School of Healthy Aging, Aesthetic and Regenerative Medicine, Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia have published the research: Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple-Negative Breast Cancer Cell Lines, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW Figure of /2022/
- what: Considering the rise in the incidence of BC, the reported adverse effects for current treatments and fewer options for TNBC patients, this study was designed to investigate the effect of calcitriol and talazoparib combination on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.